0.0001
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
22,943.0000
50,958.0000
6,387.0000
Total Liabilities Net Minority Interest
23,842.0000
14,238.0000
13,145.0000
Total Equity Gross Minority Interest
-899.0000
36,720.0000
-6,758.0000
Total Capitalization
9,449.0000
46,225.0000
-6,118.0000
Preferred Stock Equity
--
--
24,204.0000
Common Stock Equity
-899.0000
36,720.0000
-6,758.0000
Net Tangible Assets
-4,787.0000
31,643.0000
-12,313.0000
Working Capital
4,952.0000
40,518.0000
-150.0000
Invested Capital
13,981.0000
46,225.0000
-6,118.0000
Tangible Book Value
-4,787.0000
31,643.0000
-12,313.0000
Total Debt
14,880.0000
9,505.0000
640.0000
Net Debt
--
--
517.0000
Share Issued
23,851.0220
23,602.7180
23,599.7180
Ordinary Shares Number
23,851.0220
23,602.7180
23,599.7180
12/31/2020 - 10/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RLFTY Relief Therapeutics Holding SA
4.4000
0.00%
AMBS Amarantus BioScience Holdings, Inc.
0.0001
0.00%
ABVC ABVC BioPharma, Inc.
0.5200
-2.80%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
0.00%
AXIM AXIM Biotechnologies, Inc.
0.0040
+25.00%
GYRE Gyre Therapeutics, Inc.
11.50
+0.17%
ENTBF Entheon Biomedical Corp.
0.2460
0.00%
NEXI NexImmune, Inc.
0.1000
0.00%
LIXT Lixte Biotechnology Holdings, Inc.
2.4800
+0.40%
GRTX Galera Therapeutics, Inc.
0.0431
-1.15%